Medicine and Dentistry
Neoplasm
100%
Soft Tissue Sarcoma
85%
Retroperitoneal Sarcoma
76%
Recurrent Disease
63%
Gastric Bypass Surgery
62%
Gastric Bypass
62%
Diseases
60%
Sleeve Gastrectomy
55%
Overall Survival
54%
Surgical Anastomosis
54%
Connective Tissue Cancer
49%
Body Mass Index
36%
Bariatric Surgery
36%
Lymph Node Metastasis
35%
Pancreas Adenocarcinoma
29%
Metastatic Carcinoma
27%
Elderly Patient
27%
Postoperative Complication
26%
Obesity Medicine
26%
Tissue Microarray
25%
Lymph Node
24%
Liposarcoma
23%
Intraductal Papillary Mucinous Tumor
23%
Cancer
23%
Pancreas Cancer
22%
Surgical Oncology
22%
Laparoscopic Sleeve Gastrectomy
21%
Angiosarcoma
21%
Malignant Neoplasm
20%
Peritoneum Metastasis
18%
Pancreaticoduodenectomy
18%
microRNA
18%
Hyperthermic Intraperitoneal Chemotherapy
17%
Cytoreductive Surgery
16%
Protein Kinase B
16%
Pancreas Islet Cell Tumor
16%
Intraperitoneal Chemotherapy
16%
Quality of Life
16%
Roux-en-Y Gastric Bypass
15%
Sarcoma Cell
14%
Disease Specific Survival
14%
Survival Rate
14%
Surgeon
14%
Prognostic Factor
14%
Gastroesophageal Reflux
14%
Protein P53
13%
Immune Response
13%
Colorectal Surgery
12%
Desmoplasia
12%
Gastric Banding
12%
Keyphrases
Retroperitoneal Sarcoma
86%
Soft Tissue Sarcoma
79%
Sleeve Gastrectomy
58%
Tumor
51%
One-anastomosis Gastric Bypass
48%
Resection
45%
Overall Survival
41%
Bariatric Surgery
39%
Sarcoma
31%
Lymph Node Metastasis
31%
Body Mass Index
31%
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
28%
Metabolic Surgery
28%
Laparoscopic Sleeve Gastrectomy
27%
Elderly Patients
27%
Pancreatic Ductal Adenocarcinoma
26%
Sarcoma Cells
24%
Tissue Microarray
23%
Local Recurrence
23%
Chemotherapy
23%
Breast
22%
Postoperative Complications
21%
Intraductal Papillary mucinous Neoplasm
21%
Retrospective Analysis
21%
Tertiary Care Hospital
20%
Peritoneal Metastasis
19%
Surgical Oncology
19%
Pancreaticoduodenectomy
18%
Disease-specific Survival
17%
Prognosticator
17%
Cytoreductive Surgery
17%
Angiosarcoma
17%
Retroperitoneal Liposarcoma
17%
Multivariable
16%
FOLFIRINOX
16%
Neoadjuvant
16%
Roux-en-Y Gastric Bypass
16%
Total Weight Loss
16%
Gastric Bypass
16%
Postoperative Mortality
15%
Well-differentiated
15%
Colorectal Cancer
15%
Dedifferentiated
15%
Human Soft Tissue
15%
Bariatric
14%
Pancreatic Cancer
14%
Revisional
14%
Metastasis
14%
Lymph Node Ratio
14%
Postoperative Morbidity
13%